🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Express Worries

However, physicians and chemists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the service has taken down problematic content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

Within moments of entering one community, a seller posted contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Product Details and Costs

Within these groups, posts show dark colored packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to potentially significant health risks”.